rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Clinical trial NCT02340338 · COMPLETED

Trial details

NCT number: NCT02340338
Sponsor: Biomedizinische Forschungs gmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Toxic Shock Syndrome Vaccination; Sepsis

Start date: 2014-07-01
Primary completion: 2015-06-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.